The relationship between intracellular and extracellular pH in spontaneous canine tumors

Clinical Cancer Research

Volumn 6, Issue 6, 2000, Pages 2501-2505

  Prescott, Deborah M ^a   Charles, H Cecil ^a   Poulson, Jean M ^a   Page, Rodney L ^b   Thrall, Donald E ^b   Vujaskovic, Zeljko ^a   Dewhirst, Mark W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CELL PH; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG SELECTIVITY; DRUG UPTAKE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL MEMBRANE; CHLORAMBUCIL; DOGS; HYDROGEN-ION CONCENTRATION; SOFT TISSUE NEOPLASMS;

EID: 0034047785     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Vaupel, P., Kallinowski, F., and Okunieff, P. Blood flow, oxygen, nutrient supply and metabolic microenvironment of human tumors: a review. Cancer Res., 49: 6449-6465, 1989.
2. Wike-Hooley, J. L., Haveman, J., and Reinhold, H. S. The relevance of tumor pH to the treatment of malignant disease. Radiother. Oncol., 2: 343-366, 1984.
3. Gulledge, C. J., and Dewhirst, M. W. Tumor oxygenation: a matter of supply and demand. Anticancer Res., 16: 741-750, 1996.
4. Gerweck, L. E., and Seetharaman, K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res., 56: 1194-1198, 1996.
5. Simon, S., Roy, D., and Schindler, M. Intracellular pH and the control of multidrug resistance. Proc. Natl. Acad. Sci. USA, 91: 1128-1132, 1994.
6. Madshus, I. H. Regulation of intracellular pH in eukaryotic cells. Biochem. J., 250: 1-8, 1988.
7. Boyer, M. J., and Tannock, I. F. Regulation of intracellular pH in tumor cell lines: influence of microenvironmental conditions. Cancer Res., 52: 4441-4447, 1992.
8. Mikkelsen, R. B., Asher, C., and Hicks, T. Extracellular pH, transmembrane distribution and cytotoxicity of chlorambucil. Biochem. Pharmacol., 34: 2531-2534, 1985.
9. Skarsgard, L. D., Chaplin, D. J., Wilson, D. J., Skwarchuk, M. W., Vinczan, A., and Kristl, J. The effect of hypoxia and low pH on the cytotoxicity of chlorambucil. Int. J. Radiat. Oncol. Biol. Phys., 22: 737-41, 1992.
10. Parkins, C. S., Chadwick, J. A., and Chaplin, D. J. Enhancement of chlorambucil cytotoxicity by combination with flavone acetic acid in a murine tumour. Anticancer Res., 14: 1603-1608, 1994.
11. Gabr, A., Kuin, A., Aalders, M., El-Gawly, H., and Smets, L. A. Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH. Cancer Res., 57: 4811-4816, 1997.
12. Gibson, N. W., Siegel, D., and Ross, D. Mitomycin C. Cancer Chemother. Biol. Response Modif., 13: 59-68, 1992.
13. Begleiter, A., and Leith, M. K. Role of NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase) in activation of mitomycin C under acidic conditions. Mol. Pharmacol., 44: 210-215, 1993.
14. Jahde, E., Glusenkamp, K. H., Klunder, I., Hulser, D. F., Tietze, L. F., and Rajewsky, M. F. Hydrogen ion-mediated enhancement of cytotoxicity of bis-chloroethylating drugs in rat mammary carcinoma cells in vitro. Cancer Res., 49: 2965-72, 1989.
15. Atema, A., Buurman, K. J., Noteboom, E., and Smets, L. A). Potentiation of DNA-adduct formation and cytotoxicity of platinum-containing drugs by low pH. Int. J. Cancer, 54: 166-172, 1993.
16. Jahde, E., Glusenkamp, K. H., and Rajewsky, M. F. Protection of cultured malignant cells from mitoxantrone cytotoxicity by low extracellular pH: a possible mechanism for chemoresistance in vivo. Eur J. Cancer, 26: 101-106, 1990.
17. Vukovic, V., and Tannock, I. F. Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan. Br. J. Cancer, 75: 1167-1172, 1997.
18. Engin, K., Leeper, D. B., Thistlethwaite, A. J., Tupchong, L., and McFarlane, J. D. Tumor extracellular pH as a prognostic factor in thermoradiotherapy. Int. J. Radiat. Oncol. Biol. Phys., 29: 125-132, 1994.
19. Sostman, H. D., Prescott, D. M., Dewhirst, M. W., Dodge, R. K., Thrall, D. E., Page, R. L., Tucker, J. A., Harrelson, J. M., Reece, G., Leopold, K. A., Oleson, J. R., and Charles, H. C. MR imaging and spectroscopy for prognostic evaluation in soft-tissue sarcomas. Radiology, 190: 269-275, 1994.
20. Prescott, D. M., Charles, H. C., Sostman, H. D., Page, R. L., Thrall, D. E., Moore, D., Oleson, J. R., and Dewhirst, M. W. Manipulation of intra- and extracellular pH in spontaneous canine tumours by use of hyperglycaemia. Int. J. Hyperthermia, 9: 745-754, 1993.
21. Brown, T. R., Kincaid, B. M., and Ugurbil, K. NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA, 79: 3523-3526, 1982.
22. Leeper, D. B., Engin, K., Thistlethwaite, A. J., Hitchon, H. D., Dover, J. D., Li, D. J., and Tupchong, L. Human tumor extracellular pH as a function of blood glucose concentration. Int. J. Radiat. Oncol. Biol. Phys., 28: 935-943, 1994.
23. Jahde, E., Volk, T., Atema, A., Smets, L. A., Glusenkamp, K. H., and Rajewsky, M. F. pH in human tumor xenografts and transplanted rat tumors: effect of insulin, inorganic phosphate, and m-iodobenzylguanidine. Cancer Res., 52: 6209-6215, 1992.
24. Kuin, A., Smets, L., Volk, T., Paans, A., Adams, G., Atema, A., Jahde, E., Maas, A., Rajewsky, M. F., and Visser, G. Reduction of intratumoral pH by the mitochondrial inhibitor m-iodobenzylguanidine and moderate hyperglycemia. Cancer Res., 54: 3785-3792, 1994.
25. Naeslund, J., and Swenson, K. E. Investigations on the pH of malignant tumours in mice and humans after the administration of glucose. Acta Obstet. Gynecol. Scand., 32: 359-367, 1953.
26. Engin, K., Leeper, D. B., Cater, J. R., Thistlethwaite, A. J., Tupchong, L., and McFarlane, J. D. Extracellular pH distribution in human tumours. Int. J. Hyperthermia, 11: 211-216, 1995.